4.6 Article

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Article Virology

The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats

Clifton D. McKee et al.

Summary: The Nipah virus outbreaks in Bangladesh are linked to climatic conditions, the size and distribution of bat roosts, and land-use changes over the past 300 years. 53% of winter spillover events are associated with winter temperature, impacting bat behavior, physiology, and human risk behaviors. Changes in forest cover suggest a historical shift in bat roosting behavior, leading to conditions favoring viral spillover.

VIRUSES-BASEL (2021)

Article Medicine, General & Internal

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

Ann R. Falsey et al.

Summary: The clinical trial in the United States, Chile, and Peru showed that the AZD1222 vaccine was both safe and effective in preventing symptomatic and severe Covid-19 cases, with an overall estimated efficacy of 74% and a higher efficacy of 83.5% in participants 65 years of age or older. The high vaccine efficacy was consistent across various demographic subgroups, and antibodies increased significantly after each dose.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Article Immunology

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

Thomas W. Geisbert et al.

Summary: A human subunit vaccine based on the attachment glycoprotein of Hendra virus was found to provide protection against both Nipah and Hendra viruses in a nonhuman primate model, starting as early as 7 days post immunization with a low dose. This vaccine could potentially serve as an efficient emergency tool to control the spread of Nipah disease during outbreaks.

NPJ VACCINES (2021)

Article Medicine, General & Internal

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Amy Flaxman et al.

Summary: The study shows that an extended interval before the second dose of the AstraZeneca vaccine leads to increased antibody titres, while a third dose significantly boosts antibody levels and enhances T-cell responses.

LANCET (2021)

Article Multidisciplinary Sciences

A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques

Neeltje van Doremalen et al.

SCIENCE ADVANCES (2020)

Article Multidisciplinary Sciences

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

Vincent J. Munster et al.

NATURE (2020)

Article Multidisciplinary Sciences

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Neeltje van Doremalen et al.

NATURE (2020)

Article Virology

Vaccines to Emerging Viruses: Nipah and Hendra

Moushimi Amaya et al.

ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)

Article Medicine, General & Internal

Transmission of Nipah Virus-14 Years of Investigations in Bangladesh

Birgit Nikolay et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Immunology

Henipavirus infection of the central nervous system

Brian E. Dawes et al.

PATHOGENS AND DISEASE (2019)

Article Immunology

Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018

Govindakarnavar Arunkumar et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Article Public, Environmental & Occupational Health

Gamma Irradiation as an Effective Method for Inactivation of Emerging Viral Pathogens

Friederike Feldmann et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)

Article Virology

Transmission of henipaviruses

Sarah Weatherman et al.

CURRENT OPINION IN VIROLOGY (2018)

Article Immunology

Hendra virus and Nipah virus animal vaccines

Christopher C. Broder et al.

VACCINE (2016)

Article Immunology

Effective Chemical Inactivation of Ebola Virus

Elaine Haddock et al.

EMERGING INFECTIOUS DISEASES (2016)

Article Microbiology

Foodborne Transmission of Nipah Virus in Syrian Hamsters

Emmie de Wit et al.

PLOS PATHOGENS (2014)

Article Infectious Diseases

Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster

Blair L. DeBuysscher et al.

PLOS NEGLECTED TROPICAL DISEASES (2013)

Article Pathology

RNAscope A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded Tissues

Fay Wang et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2012)

Article Cell Biology

A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge

Katharine N. Bossart et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Immunology

Person-to-person transmission of Nipah virus in a Bangladeshi community

Emily S. Gurley et al.

EMERGING INFECTIOUS DISEASES (2007)

Article Biochemical Research Methods

A time- and cost-efficient system for high-level protein production in mammalian cells

A. Radu Aricescu et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)

Article Clinical Neurology

Relapsed and late-onset Nipah encephalitis

CT Tan et al.

ANNALS OF NEUROLOGY (2002)

Article Multidisciplinary Sciences

Nipah virus: A recently emergent deadly paramyxovirus

KB Chua et al.

SCIENCE (2000)

Article Biochemical Research Methods

Accelerated titering of adenoviruses

B Bewig et al.

BIOTECHNIQUES (2000)